Cook launches new endoscope; Boston Scientific completes atrial flutter trial;

@FierceMedDev: India draws industry ire with stent reimbursement reduction. Article | Follow @FierceMedDev

@MarkHFierce: Some VC love has gone to a Spanish diagnostics start-up, to the tune of $22.1 million. Release | Follow @MarkHFierce

 @DamianFierce: Parexel is spending $24M to bolster its consulting services and predicting a strong 2013. Story | Follow @DamianFierce

> Cook Medical is debuting a new endoscopic tool surgeons can throw out after 10 uses. Item

> Boston Scientific ($BSX) has wrapped up its first-in-man trial of the IntellaTip MiFi ablation catheter, designed to treat atrial flutter. News

> Vertos Medical, a developer of percutaneous devices to treat spinal diseases, has raised $1.8 million in new financing. Item

> Solta Medical warned of potential problems concerning its $30.5 million acquisition of Sound Surgical, in part concerning a potential settlement of product liability lawsuits that could exceed available insurance coverage that would pay them. Story

> French devicemaker Mauna Kea gained 510(k) clearance of a new device made to biopsy pancreatic cysts during endoscopic needle aspiration procedures. Story

> Iowa's IDx won a CE mark for its IDx-DR diagnostic device. More

> India's current medical device regulations are largely ineffective, according to a scientist, and that will need to change if the local industry continues to grow at a high rate. Article

Biotech News

@FierceBiotech: NeuroPhage banks $6.4M for Alzheimer's drug development effort. Item | Follow @FierceBiotech

@JohnCFierce: AbbVie gains inside "breakthrough" track at FDA for hot hep C combo. News | Follow @JohnCFierce

@RyanMFierce: NeuroPhage found $6.4m for work on lead Alzheimer's candidate. Corporates Shire and Merieux invested. Release | Follow @RyanMFierce

> Bristol-Myers, AstraZeneca report positive data for rare metabolic disease drug. Article

> Novartis promises to test the full value of FDA's 'breakthrough' status. More

> Celgene turns to Concert for $300M deuterium-tweaking cancer collaboration. Story

Pharma News

@FiercePharma: J&J issue in South Korea reminiscent of OTC problems here: Ordered to halt production of recalled Children's Tylenol: More | Follow @FiercePharma

@EricPFierce: Medicare spending growth so slow that Independent Payment Board won't be in play for 2015 drug pricing. Item | Follow @EricPFierce

> Covidien predicts up to 11% sales growth at soon-to-be independent Mallinckrodt unit. Report

> Merck wins FDA nod for new Zetia-Lipitor combo, despite lack of outcomes benefit. Story

> Pfizer combats online fakes with direct-to-patient Viagra sales. Article

CRO News

> Welsh CRO Simbec goes independent with new investment. Item

> CRO Novotech picks up PE investment to expand in Asia. News

> TFS buys Beardsworth to expand oncology trial work. Article

> Covance dials up projections after strong Q1. More

Biotech IT News

> Doc launches user-friendly website for clinical trials searches. More

> Martin Leach's 16-year interview for the job of Big Data boss at Biogen Idec. Editor's corner

> IMS Health acquires social media analytics startup Semantelli. Report

> Comprehend, GNS reach milestones with software for drug researchers. Article

> Sanofi teams with Big Data outfit to research drugs for diabetes and cancer. Story

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.